Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA.
Tissue Eng Part B Rev. 2021 Jun;27(3):199-214. doi: 10.1089/ten.TEB.2020.0132. Epub 2020 Sep 25.
Inadequate vascularization of engineered tissue constructs is a main challenge in developing a clinically impactful therapy for large, complex, and recalcitrant bone defects. It is well established that bone and blood vessels form concomitantly during development, as well as during repair after injury. Endothelial cells (ECs) and mesenchymal stromal cells (MSCs) are known to be key players in orthopedic tissue regeneration and vascularization, and these cell types have been used widely in tissue engineering strategies to create vascularized bone. Coculture studies have demonstrated that there is crosstalk between ECs and MSCs that can lead to synergistic effects on tissue regeneration. At the same time, the complexity in fabricating, culturing, and characterizing engineered tissue constructs containing multiple cell types presents a challenge in creating multifunctional tissues. In particular, the timing, spatial distribution, and cell phenotypes that are most conducive to promoting concurrent bone and vessel formation are not well understood. This review describes the processes of bone and vascular development, and how these have been harnessed in tissue engineering strategies to create vascularized bone. There is an emphasis on interactions between ECs and MSCs, and the culture systems that can be used to understand and control these interactions within a single engineered construct. Developmental engineering strategies to mimic endochondral ossification are discussed as a means of generating vascularized orthopedic tissues. The field of tissue engineering has made impressive progress in creating tissue replacements. However, the development of larger, more complex, and multifunctional engineered orthopedic tissues will require a better understanding of how osteogenesis and vasculogenesis are coupled in tissue regeneration. Impact statement Vascularization of large engineered tissue volumes remains a challenge in developing new and more biologically functional bone grafts. A better understanding of how blood vessels develop during bone formation and regeneration is needed. This knowledge can then be applied to develop new strategies for promoting both osteogenesis and vasculogenesis during the creation of engineered orthopedic tissues. This article summarizes the processes of bone and blood vessel development, with a focus on how endothelial cells and mesenchymal stromal cells interact to form vascularized bone both during development and growth, as well as tissue healing. It is meant as a resource for tissue engineers who are interested in creating vascularized tissue, and in particular to those developing cell-based therapies for large, complex, and recalcitrant bone defects.
工程化组织构建物的血管化不足是开发针对大型、复杂和难治性骨缺损具有临床影响力的治疗方法的主要挑战。众所周知,骨骼和血管在发育过程中以及受伤后修复过程中是同时形成的。内皮细胞(ECs)和间充质基质细胞(MSCs)被认为是骨科组织再生和血管生成的关键参与者,这些细胞类型已广泛用于组织工程策略来创建血管化骨。共培养研究表明,ECs 和 MSCs 之间存在相互作用,可导致组织再生的协同效应。同时,制造、培养和表征包含多种细胞类型的工程化组织构建物的复杂性在创建多功能组织方面带来了挑战。特别是,促进骨和血管同时形成的最有利于促进骨和血管同时形成的时间、空间分布和细胞表型尚不清楚。
本综述描述了骨骼和血管的发育过程,以及如何利用这些过程来开发血管化骨的组织工程策略。重点介绍了 ECs 和 MSCs 之间的相互作用,以及可用于在单个工程化构建物中理解和控制这些相互作用的培养系统。讨论了模拟软骨内骨化的发育工程策略,作为生成血管化骨科组织的一种手段。组织工程领域在创建组织替代物方面取得了令人瞩目的进展。然而,要开发更大、更复杂和多功能的工程化骨科组织,需要更好地了解成骨和血管生成在组织再生过程中是如何偶联的。
血管化大型工程化组织体积仍然是开发新型、更具生物学功能的骨移植物的挑战。需要更好地了解骨骼形成和再生过程中血管是如何发育的。然后,可以将这些知识应用于开发新的策略,以在工程化骨科组织的创建过程中促进成骨和血管生成。
本文总结了骨骼和血管发育的过程,重点介绍了内皮细胞和间充质基质细胞如何在发育和生长过程中以及组织愈合过程中相互作用形成血管化骨。这是对有兴趣创建血管化组织的组织工程师的资源,特别是对那些针对大型、复杂和难治性骨缺损开发基于细胞的治疗方法的组织工程师。